Safety, acceptability, and pharmacokinetics of a monoclonal antibody-based vaginal multipurpose prevention film (MB66): A Phase I randomized trial.

Safety, acceptability, and pharmacokinetics of a monoclonal antibody-based vaginal multipurpose prevention film (MB66): A Phase I randomized trial.

<h4>Background</h4>MB66 film is a multipurpose prevention technology (MPT) product with monoclonal antibodies (mAbs) against HIV-1 (VRC01-N) and HSV-1 and 2 (HSV8-N). The mAbs were produced by transient expression in Nicotiana benthamiana (N). We conducted a Phase I clinical trial to ass...

Full description

Bibliographic Details
Main Authors: Joseph A Politch, Susan Cu-Uvin, Thomas R Moench, Karen T Tashima, Jai G Marathe, Kate M Guthrie, Howard Cabral, Tara Nyhuis, Miles Brennan, Larry Zeitlin, Hans M L Spiegel, Kenneth H Mayer, Kevin J Whaley, Deborah J Anderson
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2021-02-01
Series:PLoS Medicine
Online Access:https://doi.org/10.1371/journal.pmed.1003495

Internet

https://doi.org/10.1371/journal.pmed.1003495

Similar Items